INO·45773H409·US·equity·Healthcare - Biotechnology-13D/G
INO (INOVIO PHARMACEUTICALS INC) is held by 45 institutional investors as of Q1 2026. Largest holders: FMR LLC ($16.3M), JANUS HENDERSON GROUP PLC ($5.8M), D. E. Shaw & Co., Inc. ($3.9M). Net institutional sentiment: Mixed.
See how INO's score breaks down across 4 SEC sources
Showing 1-20 of 54
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer